| Polysporin (Ointment) (U.S.N.L.M.) | ||
|---|---|---|
|
There is no ophthalmic ointment or solution tradenamed "Polysporin" sold in the U.S. It is a popular OTC solution in Canada and a common dermatological ointment labeled "not for use in the eye" sold in the U.S. Ophthalmic bacitracin zinc / polymyxin B sulfate ointments in the U.S. are tradenamed: Polycin and AK-Poly Bac. There is no ophthalmic ointment or solution tradenamed "Polysporin" sold in the U.S. It is a popular OTC solution in Canada and a common dermatological ointment labeled "not for use in the eye" sold in the U.S. Ophthalmic bacitracin zinc / polymyxin B sulfate ointments in the U.S. are tradenamed: Polycin and AK-Poly Bac. | ||
| Dosing/ | Apply every 3 or 4 hours for 7 to 10 days Often used for PM coverage with corneal infections |
|
| Chem Specs | bacitracin zinc 500 units, polymyxin b sulfate 10,000 units | |
| Quantities | 3.5 gm tube | |
| Cost | 21.08 | |
| Class | cyclic peptid / cationic surfactant | |
| Action | Bacitracin interferes with cell wall synthesis. Polymyxin b increases permeability of bacterial cell membrane |
|
| Activity | Bacitracin primarily active against gram positive bacteria. Polymyxin B primarily active against gram negative aerobic bacteria. |
|
| Usage | Indicated for superficial conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. |
|
| Contraindications | Hypersensitivity to any of its components. | |
| Pediatric use | Safety and effectiveness in children not established. | |
| Pregnancy | Category C. No adequate controlled studies. | |
| Active against Staphylococcus aureus, streptococci including Streptococcus pneumoniae, Haemophilus influenzae, Neisseria species, and Pseudomonas aeruginosa. Active against Staphylococcus aureus, streptococci including Streptococcus pneumoniae, Haemophilus influenzae, Neisseria species, and Pseudomonas aeruginosa. |
||
| generic brands: AK-Poly Bac, Polycin, Polycin-B, | ||